Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents

Paolo Mulatero, Michael Stowasser, Keh Chuan Loh, Carlos E. Fardella, Richard D. Gordon, Lorena Mosso, Celso E. Gomez-Sanchez, Franco Veglio, William Francis Young

Research output: Contribution to journalArticle

641 Citations (Scopus)

Abstract

Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account for less than 1% of hypertensive patients. Hypokalemia was considered a prerequisite for pursuing diagnostic tests for PA. Recent studies applying the plasma aldosterone/plasma renin activity ratio (ARR) as a screening test have reported a higher prevalence. This study is a retrospective evaluation of the diagnosis of PA from clinical centers in five continents before and after the widespread use of the ARR as a screening test. The application of this strategy to a greater number of hypertensives led to a 5- to 15-fold increase in the identification of patients affected by PA. Only a small proportion of patients (between 9 and 37%) were hypokalemic. The annual detection rate of aldosterone-producing adenoma (APA) increased in all centers (by 1.3-6.3 times) after the wide application of ARR. Aldosterone-producing adenomas constituted a much higher proportion of patients with PA in the four centers that employed adrenal venous sampling (28-50%) than in the center that did not (9%). In conclusion, the wide use of the ARR as a screening test in hypertensive patients led to a marked increase in the detection rate of PA.

Original languageEnglish (US)
Pages (from-to)1045-1050
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number3
DOIs
StatePublished - Mar 2004

Fingerprint

Hyperaldosteronism
Aldosterone
Renin
Plasmas
Screening
Adenoma
Hypokalemia
Routine Diagnostic Tests
Thermodynamic properties
Sampling
Hypertension

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. / Mulatero, Paolo; Stowasser, Michael; Loh, Keh Chuan; Fardella, Carlos E.; Gordon, Richard D.; Mosso, Lorena; Gomez-Sanchez, Celso E.; Veglio, Franco; Young, William Francis.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 3, 03.2004, p. 1045-1050.

Research output: Contribution to journalArticle

Mulatero, P, Stowasser, M, Loh, KC, Fardella, CE, Gordon, RD, Mosso, L, Gomez-Sanchez, CE, Veglio, F & Young, WF 2004, 'Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents', Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 3, pp. 1045-1050. https://doi.org/10.1210/jc.2003-031337
Mulatero, Paolo ; Stowasser, Michael ; Loh, Keh Chuan ; Fardella, Carlos E. ; Gordon, Richard D. ; Mosso, Lorena ; Gomez-Sanchez, Celso E. ; Veglio, Franco ; Young, William Francis. / Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. In: Journal of Clinical Endocrinology and Metabolism. 2004 ; Vol. 89, No. 3. pp. 1045-1050.
@article{e73d7a7ce9c943ae8a8ee3ca206eec34,
title = "Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents",
abstract = "Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account for less than 1{\%} of hypertensive patients. Hypokalemia was considered a prerequisite for pursuing diagnostic tests for PA. Recent studies applying the plasma aldosterone/plasma renin activity ratio (ARR) as a screening test have reported a higher prevalence. This study is a retrospective evaluation of the diagnosis of PA from clinical centers in five continents before and after the widespread use of the ARR as a screening test. The application of this strategy to a greater number of hypertensives led to a 5- to 15-fold increase in the identification of patients affected by PA. Only a small proportion of patients (between 9 and 37{\%}) were hypokalemic. The annual detection rate of aldosterone-producing adenoma (APA) increased in all centers (by 1.3-6.3 times) after the wide application of ARR. Aldosterone-producing adenomas constituted a much higher proportion of patients with PA in the four centers that employed adrenal venous sampling (28-50{\%}) than in the center that did not (9{\%}). In conclusion, the wide use of the ARR as a screening test in hypertensive patients led to a marked increase in the detection rate of PA.",
author = "Paolo Mulatero and Michael Stowasser and Loh, {Keh Chuan} and Fardella, {Carlos E.} and Gordon, {Richard D.} and Lorena Mosso and Gomez-Sanchez, {Celso E.} and Franco Veglio and Young, {William Francis}",
year = "2004",
month = "3",
doi = "10.1210/jc.2003-031337",
language = "English (US)",
volume = "89",
pages = "1045--1050",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents

AU - Mulatero, Paolo

AU - Stowasser, Michael

AU - Loh, Keh Chuan

AU - Fardella, Carlos E.

AU - Gordon, Richard D.

AU - Mosso, Lorena

AU - Gomez-Sanchez, Celso E.

AU - Veglio, Franco

AU - Young, William Francis

PY - 2004/3

Y1 - 2004/3

N2 - Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account for less than 1% of hypertensive patients. Hypokalemia was considered a prerequisite for pursuing diagnostic tests for PA. Recent studies applying the plasma aldosterone/plasma renin activity ratio (ARR) as a screening test have reported a higher prevalence. This study is a retrospective evaluation of the diagnosis of PA from clinical centers in five continents before and after the widespread use of the ARR as a screening test. The application of this strategy to a greater number of hypertensives led to a 5- to 15-fold increase in the identification of patients affected by PA. Only a small proportion of patients (between 9 and 37%) were hypokalemic. The annual detection rate of aldosterone-producing adenoma (APA) increased in all centers (by 1.3-6.3 times) after the wide application of ARR. Aldosterone-producing adenomas constituted a much higher proportion of patients with PA in the four centers that employed adrenal venous sampling (28-50%) than in the center that did not (9%). In conclusion, the wide use of the ARR as a screening test in hypertensive patients led to a marked increase in the detection rate of PA.

AB - Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account for less than 1% of hypertensive patients. Hypokalemia was considered a prerequisite for pursuing diagnostic tests for PA. Recent studies applying the plasma aldosterone/plasma renin activity ratio (ARR) as a screening test have reported a higher prevalence. This study is a retrospective evaluation of the diagnosis of PA from clinical centers in five continents before and after the widespread use of the ARR as a screening test. The application of this strategy to a greater number of hypertensives led to a 5- to 15-fold increase in the identification of patients affected by PA. Only a small proportion of patients (between 9 and 37%) were hypokalemic. The annual detection rate of aldosterone-producing adenoma (APA) increased in all centers (by 1.3-6.3 times) after the wide application of ARR. Aldosterone-producing adenomas constituted a much higher proportion of patients with PA in the four centers that employed adrenal venous sampling (28-50%) than in the center that did not (9%). In conclusion, the wide use of the ARR as a screening test in hypertensive patients led to a marked increase in the detection rate of PA.

UR - http://www.scopus.com/inward/record.url?scp=1642390149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642390149&partnerID=8YFLogxK

U2 - 10.1210/jc.2003-031337

DO - 10.1210/jc.2003-031337

M3 - Article

C2 - 15001583

AN - SCOPUS:1642390149

VL - 89

SP - 1045

EP - 1050

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -